-
FDA approves oral version of weight-loss drug semaglutide, UAB researchers reactMultisite research, including research at UAB, shows that oral semaglutide is nearly as effective as the widely used injectable version for treating obesity, delivering about 13.7 percent average weight loss over 64 weeks. -
-
-
-
-
-
UAB to evaluate the impact of neighborhood revitalization on residents’ lung healthIn partnership with the Housing Authority of the Birmingham District, the City of Birmingham and community partners, UAB will assess the effectiveness of public housing renovations and environmental refinements on community health. -
-
-
-
-